TRDA FY 2020 Earnings — Entrada Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

TRDAEntrada Therapeutics, Inc.

$502M

FY 2020 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$0

Gross Profit

-$326,000

Operating Income

-$27M

Net Income

-$27M

EPS (Diluted)

$-0.84

Cash Flow

Operating Cash Flow

-$26M

Free Cash Flow

-$28M

Stock-Based Comp.

$325,000

Balance Sheet

Total Assets

$44M

Total Liabilities

$85M

Stockholders' Equity

-$41M

Cash & Equivalents

$39M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$326,000	-$104,000	-213.5%
Operating Income	-$27M	-$12M	-125.5%
Net Income	-$27M	-$5M	-470.5%